Adicet Bio, Inc. Employee Count
The employee counts Adicet Bio, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 102; Filing 2026-03-12; Lease expense per employee $37,196.08.
- 2024-12-31: Employees (as filed) 152; Filing 2025-03-06; Lease expense per employee $25,993.42.
- 2023-12-31: Employees (as filed) 143; Filing 2024-03-19; Lease expense per employee $27,909.09.
- 2022-12-31: Employees (as filed) 132; Filing 2023-03-15; Lease expense per employee $29,825.76.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 102 full-time | 2026-03-12 | $37,196.08 total lease cost |
| 2024-12-31 | 152 full-time | 2025-03-06 | $25,993.42 total lease cost |
| 2023-12-31 | 143 full-time | 2024-03-19 | $27,909.09 total lease cost |
| 2022-12-31 | 132 full-time | 2023-03-15 | $29,825.76 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |